120
Views
20
CrossRef citations to date
0
Altmetric
Review

A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil

&
Pages 1159-1164 | Published online: 12 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Li Smith-Harrison, Nathan R. Starke, Ryan P. Smith & Jason R. Kovac. (2017) Drugs in preclinical to phase II clinical development for the treatment of erectile dysfunction. Expert Opinion on Investigational Drugs 26:6, pages 669-675.
Read now
Igor Voznesensky, Kenneth J. DeLay & Wayne J. G. Hellstrom. (2016) Advances in pharmacotherapy for erectile dysfunction and associated cardiac impact. Expert Opinion on Pharmacotherapy 17:17, pages 2281-2289.
Read now
Luca Boeri, Paolo Capogrosso, Eugenio Ventimiglia, Alessandro Serino, Giovanni La Croce, Andrea Russo, Rocco Damiano, Francesco Montorsi & Andrea Salonia. (2016) Avanafil - a further step to tailoring patient needs and expectations. Expert Review of Clinical Pharmacology 9:9, pages 1171-1181.
Read now

Articles from other publishers (17)

Waye‐Hann Kang, Muhammad Navid Mohamad Sithik, Jun‐Kit Khoo, Ying‐Guat Ooi, Quan‐Hziung Lim & Lee‐Ling Lim. (2022) Gaps in the management of diabetes in Asia: A need for improved awareness and strategies in men's sexual health. Journal of Diabetes Investigation 13:12, pages 1945-1957.
Crossref
Inbal Itzhak, Shira Cohen, Sari Fishman & Pnina Fishman. (2022) A3 adenosine receptor allosteric modulator CF602 reverses erectile dysfunction in a diabetic rat model . Andrologia 54:9.
Crossref
О.М. Gopchuk & Р.V. Samaniv. (2022) Problems of the thin endometrium. New possibilities of FDE-5 inhibitors. Reproductive health of woman:2, pages 47-52.
Crossref
Islam Fathy Soliman Abdelrahman, Amr Abdel Raheem, Yaser Elkhiat, Abdelrahman A. Aburahma, Tarek Abdel‐Raheem & Hussein Ghanem. (2021) Safety and efficacy of botulinum neurotoxin in the treatment of erectile dysfunction refractory to phosphodiesterase inhibitors: Results of a randomized controlled trial. Andrology 10:2, pages 254-261.
Crossref
Luis Fernando Valladales-Restrepo & Jorge Enrique Machado-Alba. (2020) Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction. International Journal of Clinical Pharmacy 43:4, pages 900-908.
Crossref
Yurii Gurzhenko & Volodymyr Spyrydonenko. (2021) Theoretical Substantiation of the Use of Sildenafil in the Treatment of Chronic Prostatitis. Health of Man:2, pages 58-62.
Crossref
В. В. Спиридоненко. (2019) Avanafil – a New Means for Treating Erectile Dysfunction in the Ukraine Market. Health of Man:4, pages 57-62.
Crossref
Catherine R. Weiler, K. Frank Austen, Cem Akin, Marla S. Barkoff, Jonathan A. Bernstein, Patrizia Bonadonna, Joseph H. Butterfield, Melody Carter, Charity C. Fox, Anne Maitland, Thanai Pongdee, S. Shahzad Mustafa, Anupama Ravi, Mary C. Tobin, Harissios Vliagoftis & Lawrence B. Schwartz. (2019) AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management. Journal of Allergy and Clinical Immunology 144:4, pages 883-896.
Crossref
Samir Sami, Noah Stern, Andrew Di Pierdomenico, Brandon Katz & Gerald Brock. (2019) Erectile Dysfunction: A Primer for in Office Management. Medical Sciences 7:9, pages 90.
Crossref
Cassia Regina Gontijo Gomes, Aline Helena Appoloni Eduardo, María-Pilar Mosteiro-Diaz, Javier Pérez-Paniagua & Anamaria Alves Napoleão. (2019) Intervenções de enfermagem para incontinência urinária e disfunção sexual após prostatectomia radical. Acta Paulista de Enfermagem 32:1, pages 106-112.
Crossref
S. I. Gamidov, T. V. Shatylko, N. G. Gasanov & N. A. Naumov. (2018) The use of tadalafil on demand in specific categories of patients. Andrology and Genital Surgery 19:4, pages 15-20.
Crossref
Phelan E. Maruca-Sullivan, Sarah A. Kleinfeld & Kirsten M. Wilkins. (2018) Treatment Approaches to Sexual Dysfunction in Late Life. Current Treatment Options in Psychiatry 5:2, pages 255-274.
Crossref
Binbin Gong, Ming Ma, Wenjie Xie, Xiaorong Yang, Yongming Huang, Ting Sun, Yanping Luo & Jiao Huang. (2017) Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. International Urology and Nephrology 49:10, pages 1731-1740.
Crossref
Fabio Pezzoni, Fabrizio Ildefonso Scroppo & Giorgio Cavallini. (2017) Differences in Cavernosal Artery Parameters According to Different Anatomic Sampling Locations During the Diagnosis of Vascular Erectile Dysfunction Using Duplex Ultrasound. Urology 105, pages 33-41.
Crossref
Francesco Scaglione, Shaantanu Donde, Tarek A. Hassan & Emmanuele A. Jannini. (2017) Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation. Clinical Therapeutics 39:2, pages 370-377.
Crossref
Joan Somes & Nancy Stephens Donatelli. (2016) Nitroglycerin? Yes or No? That Is the Question! Risk of Administering Sublingual Nitroglycerin When the Patient Is Using Phosphodiesterase-5 Inhibitors. Journal of Emergency Nursing 42:5, pages 434-437.
Crossref
Susann Schröder, Barbara Wenzel, Winnie Deuther-Conrad, Matthias Scheunemann & Peter Brust. (2016) Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012. Molecules 21:5, pages 650.
Crossref